| Target Price | $3.06 |
| Price | $1.23 |
| Potential |
148.78%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target InflaRx N.V. 2026 .
The average InflaRx N.V. target price is $3.06.
This is
148.78%
register free of charge
$10.50
753.66%
register free of charge
$2.02
64.23%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend InflaRx N.V. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the InflaRx N.V. stock has an average upside potential 2026 of
148.78%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.19 | 0.09 |
| 171.43% | 50.68% | |
| EBITDA Margin | -31,973.68% | -71,788.41% |
| 56.34% | 124.52% | |
| Net Margin | -28,047.37% | -55,950.07% |
| 60.22% | 99.48% |
9 Analysts have issued a sales forecast InflaRx N.V. 2025 . The average InflaRx N.V. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an InflaRx N.V. EBITDA forecast 2025. The average InflaRx N.V. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 InflaRx N.V. Analysts have issued a net profit forecast 2025. The average InflaRx N.V. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.90 | -0.77 |
| 0.00% | 14.44% | |
| P/E | negative | |
| EV/Sales | 296.48 |
9 Analysts have issued a InflaRx N.V. forecast for earnings per share. The average InflaRx N.V. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 29 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 29 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 26 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


